[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100630349":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":32,"collaborators":7,"id":36,"slug":7,"hasResults":37,"nctId":38,"briefTitle":39,"officialTitle":39,"acronym":40,"eligibilityCriteria":41,"healthyVolunteers":42,"sex":43,"minAge":44,"maxAge":7,"enrollmentInfo":45,"targetDuration":7,"studyType":48,"phases":7,"briefSummary":49,"conditions":50,"keywords":7,"overallStatus":53,"whyStopped":7,"lastUpdateSubmitDate":54,"lastUpdatePostDateStruct":55,"startDateStruct":58,"completionDateStruct":60,"leadSponsor":62,"locationsCount":63},{"fullName":5,"class":6},"Asian Institute of Gastroenterology, India","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Dr.Hardik Rughwani Dr.Hardik Rughwani, MBBS, MD, DM","CONTACT","+91-9426928600","hardik.hr@gmail.com",[15],{"facility":16,"status":7,"city":17,"state":18,"zip":19,"country":20,"cosmosGeoPoint":21,"geoPoint":26,"contacts":27},"AIG Hospitals","Hyderabad","Telangana","500032","India",{"type":22,"coordinates":23},"Point",[24,25],78.45636,17.38405,{"lat":25,"lon":24},[28],{"name":29,"role":11,"phone":30,"phoneExt":7,"email":31},"Sana Fathima Facility Contact","9182859523","aigresearch7@gmail.com",{"type":33,"investigatorFullName":34,"investigatorTitle":35,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Mohan Ramchandani","Director, Department of Interventional Endoscopy","100630349",false,"NCT07486518","A Multicentre Observational Cross-Sectional Study of The Gastric Precancerous Epithelial Pathway Using High-Definition Endoscopy And Histopathology In India","IND-PREP","1. Adults aged ≥40 years undergoing upper gastrointestinal endoscopy for dyspepsia or other clinical indications (nonalarming and alarming symptoms both).\n2. Ability to provide written informed consent.\n\nExclusion Criteria:\n\n1. Known gastric malignancy.\n2. Prior gastric surgery (excluding H. pylori eradication).\n3. Contraindications to endoscopy or biopsy.\n4. Known hereditary gastric cancer syndromes.",true,"ALL","40 Years",{"count":46,"type":47},4000,"ESTIMATED","OBSERVATIONAL","To estimate the prevalence of histologically confirmed early gastric cancer (EGC) in an Indian multicentre cohort undergoing standardised high-quality upper gastrointestinal endoscopy. EGC is defined as gastric adenocarcinoma confined to the mucosa or submucosa (T1), irrespective of lymph node status, based on histopathology.",[51,52],"Gastric Adenocarcinoma","Early Gastric Cancer","NOT_YET_RECRUITING","2026-06-02",{"date":56,"type":57},"2026-06-04","ACTUAL",{"date":59,"type":47},"2026-07-01",{"date":61,"type":47},"2028-07-01",{"name":5,"class":6},1]